Viral Variant Conversations - Improving the understanding of SARS-CoV-2 variants in Malawi
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 223271/Z/21/A
Grant search
Key facts
Disease
COVID-19Start & end year
20222023Known Financial Commitments (USD)
$59,775.93Funder
Wellcome TrustPrincipal Investigator
Prof Sharon James PeacockResearch Location
United KingdomLead Research Institution
University of CambridgeResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Community engagement
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Other
Abstract
The introduction of SARS-CoV-2 sequencing to new settings during the COVID-19 pandemic can be hampered by a lack of understanding of the value of genomic surveillance and concerns which may be amplified by alarmist media messaging. Clear public engagement to accompany SARS-CoV-2 sequencing training is beneficial to ensure maximum public health benefit. We will use the combined sequencing and communications expertise of COG-Train (University of Cambridge) with the public engagement, radio and co-production experience of the Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW) to improve public and community engagement in Malawi. We will deliver in-person and online training courses in the communication of SARS-CoV-2 variant information to scientists and public health officials in Malawi. The courses will be devised by communications specialists at the Malawi University of Business Studies using COG-Train material and include collaborative consultations via established radio listening clubs. A series of eight radio programmes will be aired and feedback collected from audiences. The training material and broadcasts will be repackaged to create online resources suitable for sharing with the Wellcome Africa and Asia Partnership (AAP) countries. We hope that the proposal will contribute to an open environment where trustworthy genomics research can benefit all of society.